← Open Payments lookup

SUSAN CANDELARIA: Open Payments

NPI 1992396998 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,619 in 72 payments from 15 companies in 2025. Trend: 2023 $952 · 2024 $1,199 · 2025 $1,619

Food & beverage: $1,619
CompanyPaymentsAmount
ABBVIE INC.22$562
Otsuka America Pharmaceutical, Inc.16$290
Indivior Inc.5$115
Neurocrine BioSciences, Inc.4$96
E.R. Squibb & Sons, L.L.C.3$87
Lundbeck LLC5$86
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$72
Janssen Pharmaceuticals, Inc3$68
Braeburn Inc.2$65
Axsome Therapeutics, Inc.2$47

Products named: VRAYLAR, REXULTI, SUBLOCADE, INGREZZA, COBENFY, ABILIFY ASIMTUFII, CAPLYTA, SPRAVATO.

Industry payments across NV — which companies pay providers there.